• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

NVA donates $10 million to Ethos Discovery

August 23, 2022
dvm360 Staff

Funds will support innovation in veterinary medicine to enhance the lives of pets and pet owners

National Veterinary Associates (NVA), an international pet care organization and community of veterinary clinics and pet resorts, has granted a $10 million donation to Ethos Discovery, a nonprofit incubator committed to accelerating veterinary medicine. NVA’s donation will offer a foundation for the organization’s endowment fund and provide continual funding for research projects that transform the future of veterinary care for pets and pet owners.

“NVA is very proud to support the work of Ethos Discovery,” expressed Greg Hartmann, CEO of NVA, in a company release.1 “The NVA community shares a deep commitment to medical innovation and transformative care that will propel our industry forward. I am confident that our leading veterinary teams, as well as veterinary teams across the globe, will benefit from Ethos Discovery’s cutting-edge research and development of novel diagnostic and treatment options for complex medical conditions improving the lives of the pets we love.”

Ethos Discovery was founded by members of Ethos Veterinary Health, an emergency and specialty hospital group that recently joined the NVA family. Ethos Discovery works in tandem with clinical teams at Ethos Veterinary Health and partners with academics and professionals throughout the animal health industry to advance veterinary medicine.

“This is the largest contribution Ethos Discovery has received to date and will support our commitment to research, innovation and fulfilling unmet needs in veterinary medicine,” said Chand Khanna, DVM, PhD, president of Ethos Discovery. “With NVA’s support, we are well-positioned to broaden our scientific portfolio, expand the number of patients that receive care though clinical trials and accelerate our ability to deliver novel research and valuable insights. We applaud NVA’s commitment to transforming veterinary care and look forward to collaborating with their medical teams as we advance our shared commitment to medical advancement.”

Advertisement

Ethos Discovery currently has various studies with a focus on discovering cures or enhancing treatment options. Some of the promising studies include1:

  • improving the life span of dogs with Hemangiosarcoma, via new medical treatment;
  • improved care for patients undergoing chemotherapy via faster detection of low white blood cell counts and resulting risk of sepsis;
  • improved care for dogs and cats with pneumonia by creating a diagnostic test that takes hours instead of days to identify if bacteria in the lungs is antibiotic resistant.

Reference

NVA announces $10 million donation to fund clinical trials and pioneering breakthroughs in specialty and emergency medicine. News release. National Veterinary Associates. August 18, 2022. Accessed August 22, 2022. https://www.nva.com/newsroom/nva-announces-10-million-donation-to-fund-clinical-trials-and-pioneering-breakthroughs-in-specialty-and-emergency-medicine

Related Content:

Business
The Vets expands to Raleigh, NC
The Vets expands to Raleigh, NC
The 5 Ws of veterinary diagnostics contracts
The 5 Ws of veterinary diagnostics contracts
3 Must-sees from the Fetch Charlotte conference
3 Must-sees from the Fetch Charlotte conference

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement